No photo of Carrie Haskell-Luevano
Contact Expert

View Scopus Profile

Carrie Haskell-Luevano

1994 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Novel Melanocortin Receptor Probe Discovery

Haskell-Luevano, C.

NIH Natl Inst of Diabetes/Dig/Kidney Dis

4/1/16 → 3/31/21

Project: Research project

    • Discovery of Opioid Receptor Endogenous Allosteric Modul

    Haskell-Luevano, C.

    Winston & Maxine Wallin Neuro Disc Fund

    1/1/18 → 12/31/18

    Project: Research project

    • Defensins as Melanocortin Ligands

    Haskell-Luevano, C.

    NIH Natl Inst of Diabetes/Dig/Kidney Dis

    10/1/15 → 11/30/17

    Project: Research project

    • Defensins as Melanocortin Ligands

    Haskell-Luevano, C.

    NIH Natl Inst of Diabetes/Dig/Kidney Dis

    12/1/12 → 11/30/15

    Project: Research project

    • Melanocortin Selective Ligands

    Haskell-Luevano, C.

    NIH Natl Inst of Diabetes/Dig/Kidney Dis

    5/1/12 → 4/30/17

    Project: Research project

    • Research Output

    Allosteric Modulators of Drug Targets

    Haskell-Luevano, C. & Meanwell, N. A., Oct 1 2019, In : Journal of Medicinal Chemistry. 62, 1, p. 1-2 2 p.

    Research output: Contribution to journal › Editorial

    Open Access
    2 Scopus citations

    Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors

    Lensing, C. J., Freeman, K. T., Schnell, S. M., Speth, R. C., Zarth, A. T. & Haskell-Luevano, C., Jan 10 2019, In : Journal of medicinal chemistry. 62, 1, p. 144-158 15 p.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μm MC4R Partial Agonist

    Fleming, K. A., Freeman, K. T., Powers, M. D., Santos, R. G., Debevec, G., Giulianotti, M. A., Houghten, R. A., Doering, S. R., Pinilla, C. & Haskell-Luevano, C., Mar 14 2019, In : Journal of medicinal chemistry. 62, 5, p. 2738-2749 12 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Structure–activity relationships of the tetrapeptide Ac-His-Arg-(Pi)Dphe-TiC-NH2 at the mouse melanocortin receptors: Modification at the (PI)DPhe position leads to MMC3R versus MMC4R selective ligands

    Schlasner, K. N., Ericson, M. D., Doering, S. R., Freeman, K. T., Weinrich, M. & Haskell-Luevano, C., Apr 13 2019, In : Molecules. 24, 8, 1463.

    Research output: Contribution to journal › Article

    Open Access

    • 1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization

    Tala, S. R., Singh, A., Lensing, C. J., Schnell, S. M., Freeman, K. T., Rocca, J. R. & Haskell-Luevano, C., May 16 2018, In : ACS Chemical Neuroscience. 9, 5, p. 1001-1013 13 p.

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations